Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2022
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical TrialsMatthew P Smeltzer, Giorgio V Scagliotti, Heather A Wakelee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work GroupAllison Magnuson, Suanna S Bruinooge, Harpreet Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief ReportAlexander I Spira, Luis Paz-Ares, Ji-Youn Han, et al.
Journal of Oncology Practice|March 5, 2019
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical TrialsJeanne M Regnante, Nicole A Richie, Lola Fashoyin-Aje, et al.
JCO Precision Oncology|November 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker SummitDaniel F Hayes, Roy S Herbst, Jonathan L Myles, et al.
Oncotarget|April 2, 2016
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
The Lancet. Oncology|August 4, 2023
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended prioritiesMichelle M Kim, Minesh P Mehta, DeeDee K Smart, et al.
Pageof 4